Approval · Notice of Compliance 29250 · 2020
CHOLEDYL EXPECTORANT: Notice of Compliance 29250
Issued October 20, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29250
- Date
- October 20, 2020
- Company
- Searchlight Pharma Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Change in Product Ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CHOLEDYL EXPECTORANT | 00476374 | Marketed |
Medicinal ingredients
- OXTRIPHYLLINE 100 MG per 5ML
- GUAIFENESIN 50 MG per 5ML